Hydrophobic acrylic IOLs offer better low contrast visual acuity

Article

Hydrophobic acrylic IOLs give the best optical quality in pseudophakic eyes.

A study featured in the Journal of Cataract and Refractive Surgery has identified that hydrophobic acrylic IOLs give the best optical quality in pseudophakic eyes.

The comparative case series, led by Dr Mayank A. Nanavaty, St Thomas' Hospital, London, UK, involved 28 eyes fitted with hydrophilic IOLs and 43 with hydrophobic IOLs. All eyes had a clear posterior capsule within the central 4 mm and were assessed 3 months postoperatively. Outcome measures included the 10% and 50% point-spread function (PSF) values and in vitro forward-scattering.

There was no considerable difference in IOL power, postoperative spherical equivalent or 100% logMAR correct distance visual acuities (CDVA).

Between the IOL groups the results for 9% logMAR CDVA and 10% PSF, 50% PSF and Zernike polynomial were significantly different. It was found that hydrophilic IOLs had more forward scatter.

Overall, the hydrophobic acrylic IOL produced greater optical quality and better low contrast visual acuity compared to the hydrophilic IOL. The study suggests the material of the IOL should be considered for pseudophakic eyes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.